Literature DB >> 15050978

The role of liver transplantation in urea cycle disorders.

James V Leonard1, Peter J McKiernan.   

Abstract

Liver transplantation has an important role in the management of patients with urea cycle disorders, particularly those with severe variants, progressive liver disease, and some patients who have proved very difficult to control with conventional therapy. As a result of technical advances in liver transplantation, the outlook, both morbidity and mortality, is better and continues to improve. Patients can almost always have a normal diet and the quality of life for survivors is generally excellent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050978     DOI: 10.1016/j.ymgme.2003.08.027

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  26 in total

1.  Successful liver transplantation for argininosuccinate lyase deficiency (ASLD).

Authors:  E Robberecht; S Maesen; A Jonckheere; S Van Biervliet; D Carton
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

2.  Favorable long-term outcome following severe neonatal hyperammonemic coma in a patient with argininosuccinate synthetase deficiency.

Authors:  Isabelle De Bie; Emmanuelle Lemyre; Marie Lambert
Journal:  JIMD Rep       Date:  2011-06-22

Review 3.  The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM).

Authors:  Tatyana N Tarasenko; Peter J McGuire
Journal:  Mol Genet Metab       Date:  2017-06-24       Impact factor: 4.797

Review 4.  Urea cycle disorders-update.

Authors:  Shirou Matsumoto; Johannes Häberle; Jun Kido; Hiroshi Mitsubuchi; Fumio Endo; Kimitoshi Nakamura
Journal:  J Hum Genet       Date:  2019-05-20       Impact factor: 3.172

Review 5.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

Review 6.  Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review.

Authors:  Francesco Giuseppe Foschi; Maria Cristina Morelli; Sara Savini; Anna Chiara Dall'Aglio; Arianna Lanzi; Matteo Cescon; Giorgio Ercolani; Alessandro Cucchetti; Antonio Daniele Pinna; Giuseppe Francesco Stefanini
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

7.  Liver transplantation and cell therapies for inborn errors of metabolism.

Authors:  Patrick McKiernan
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

8.  Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome.

Authors:  Lili Wang; Hiroki Morizono; Jianping Lin; Peter Bell; David Jones; Deirdre McMenamin; Hongwei Yu; Mark L Batshaw; James M Wilson
Journal:  Mol Genet Metab       Date:  2011-11-07       Impact factor: 4.797

9.  Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?

Authors:  Shailly Jain-Ghai; Sandesh C Sreenath Nagamani; Susan Blaser; Komudi Siriwardena; Annette Feigenbaum
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

10.  Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency.

Authors:  Jacob F Collen; Nealanjon P Das; Jonathan M Koff; Robert T Neff; Kevin C Abbott
Journal:  Appl Clin Genet       Date:  2008-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.